Sinopharm Group (1099 HK): Industry Tailwind and China Reopening To Drive Growth
SinoPharm’s acquisition of VBP varieties is in the leading position in the industry. As depicted by accelerating revenues in the first three...
955 Views
China’s State Drugmakers Scramble to Stock Pharmacy Shelves Amid Run on Covid Medicines
According to data provided to Caixin by JD Health, the pharmacy platform saw an 18-fold spike in sales of anti-epidemic drugs in the week to Dec....
635 Views
CX Daily: China’s Drive to Kick the Foreign IT Habit
Covid surge leaves blood banks begging for donations around China. Key policy meeting highlights economic stability and restoring confidence. China...
630 Views
Zhangzhou Pientzehuang Pharmaceutical (600436.CH) - Disappointing Performance Is Just the Beginning
The investment logic of PienTzeHuang has changed, with more downside in valuation ahead. It's time to think about long logic from a broader...
438 Views
China Resources Pharmaceutical (3320.HK) - Here Are the Concerns
Pharmaceutical manufacturing business is the key to drive valuation,but the subsidiaries face challenge.CR Pharma should improve its vision of...
541 Views